Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12149196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracellular staining for TNF and IFN-gamma detects different frequencies of antigen-specific CD8(+) T cells.

  2000cited by this paper
• Type I and type II T‐cell profiles in aplastic anemia and refractory anemia

  2000cited by this paper
• Sustained long‐term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy

  2000cited by this paper
• Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.

  1999cited by this paper
• Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus.

  1999cited by this paper
• Successful peripheral blood stem cell transplantation for myelodysplastic syndrome

  1999cited by this paper
• Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.

  1999cited by this paper
• Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells.

  1999cited by this paper
• Single-cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols.

  1997cited by this paper
• The pathophysiology of acquired aplastic anemia.

  1997cited by this paper
• Analysis of T‐cell clonality in bone marrow of patients with acquired aplastic anaemia

  1997cited by this paper
• Hepatitis-associated aplastic anemia.

  1997cited by this paper
• Use of partially mismatched related donors extends access to allogeneic marrow transplant.

  1997cited by this paper
• Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia.

  1996cited by this paper
• Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults

  1996cited by this paper
• A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia.

  1996cited by this paper
• The treatment of severe acquired aplastic anemia.

  1995cited by this paper
• Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.

  1995cited by this paper
• Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.

  1994cited by this paper
• Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure

  1994cited by this paper
• Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

  1993cited by this paper
• Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia.

  1992cited by this paper
• Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.

  1992cited by this paper
• Correlation of response of aplastic anemia patients to antilymphocyte globulin with in vitro lymphocyte stimulatory effect: predictive value of in vitro test for clinical response.

  1991cited by this paper
• Assessment of Cytokines by Immunofluorescence and the Paraformaldehyde‐Saponin Procedure

  1991cited by this paper
• Subsets of patients with aplastic anemia identified by flow microfluorometry.

  1985cited by this paper
• Correlation of two in vitro tests with clinical response to immunosuppressive therapy in 54 patients with severe aplastic anemia.

  1984cited by this paper
• Inhibitory effects of peripheral blood cells on in vitro colony formation by autologous bone marrow in aplastic anaemia: relation with response to immunosuppressive therapy.

  1982cited by this paper
• Severe Aplastic Anaemia: Correlation of in Vitro Tests with Clinical Response to Immunosuppression in 20 Patients

  1981cited by this paper
• Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.

  1980cited by this paper
• Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

  1976cited by this paper

• Ruxolitinib reduces macrophage pyroptosis in aplastic anaemia

  2026cites this paper
• Evaluating the causal role of circulating inflammatory cytokines and plasma metabolites on aplastic anemia

  2025cites this paper
• Origins of T‐cell‐mediated autoimmunity in acquired aplastic anaemia

  2025cites this paper
• Interferon-γ-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia

  2025cites this paper
• Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy

  2025cites this paper
• Dioscin alleviates aplastic anemia through regulatory T cells promotion

  2024cites this paper
• The hematopoietic niche and the autoreactive memory in autoimmune disorders.

  2024cites this paper
• The long-term outcomes and safety of severe aplastic anemia treated with porcine antilymphocyte globulin plus cyclosporine, with or without thrombopoietin receptor agonists: a double-center retrospective study

  2024cites this paper
• The immunologic abnormalities in patients with paroxysmal nocturnal hemoglobinuria are associated with disease progression

  2024cites this paper
• Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia

  2024cites this paper
• The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults

  2024cites this paper
• Stem cell-like memory T cells: Role in viral infections and autoimmunity

  2023cites this paper
• Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility

  2023cites this paper
• Alterations of mesenchymal stem cells on regulating Th17 and Treg differentiation in severe aplastic anemia

  2023cites this paper
• Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?

  2023cites this paper
• The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?

  2022cites this paper
• Multi-Omics Profiling Identifies Pathways Associated With CD8+ T-Cell Activation in Severe Aplastic Anemia

  2022cites this paper
• Changes in bone marrow and peripheral blood lymphocyte subset findings with onset of hepatitis-associated aplastic anemia

  2022cites this paper
• Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis

  2022cites this paper
• Molecular landscape of immune pressure and escape in aplastic anemia

  2022cites this paper
• Cluster analysis of lymphocyte subset from peripheral blood in newly diagnosed idiopathic aplastic anaemia patients

  2022cites this paper
• Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag

  2022cites this paper
• Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature

  2021cites this paper
• Interferon Gamma and perforin positive T cells in acquired aplastic anemia: implication in therapeutic response.

  2021cites this paper
• The Immunogenetic Basis of Idiopathic Bone Marrow Failure Syndromes: A Paradox of Similarity and Self-Presentation

  2021cites this paper
• Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure

  2021cites this paper
• Expression and function of SLAMF6 in CD8+ T lymphocytes of patients with severe aplastic anemia.

  2021cites this paper
• Single-cell transcriptomics dissects hematopoietic cell destruction and T cell engagement in aplastic anemia.

  2021cites this paper
• CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia

  2021cites this paper
• The role of interferon‐gamma and its signaling pathway in pediatric hematological disorders

  2021cites this paper
• The Similarity of Class II HLA Genotypes Defines Patterns of Autoreactivity in Idiopathic Bone Marrow Failure Disorders.

  2021cites this paper
• Role of macrophages and phagocytes in orchestrating normal and pathological haematopoietic niches.

  2021cites this paper
• Hepatitis-associated aplastic anemia in pediatric patients: single center experience.

  2020cites this paper
• Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress

  2020cites this paper
• High-Dose Aluminum Exposure Further Alerts Immune Phenotype in Aplastic Anemia Patients

  2020cites this paper
• Effect of arsenic trioxide on the Tregs ratio and the levels of IFN-γ, IL-4, IL-17 and TGF-β1 in the peripheral blood of severe aplastic anemia patients

  2020cites this paper
• Diacylglycerol kinase ζ deficiency triggers early signs of aplastic anemia in mice

  2020cites this paper
• Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.

  2020cites this paper
• Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure.

  2019cites this paper
• Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.

  2019cites this paper
• Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia

  2018cites this paper
• Advances in understanding the pathogenesis of acquired aplastic anaemia

  2018cites this paper
• Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.

  2018cites this paper
• 重型再生障碍性贫血患者免疫抑制治疗疗效预测及恢复规律研究进展

  2018cites this paper
• 重型再生障碍性贫血患者SLAMF6表达状态的初步研究

  2018cites this paper
• The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited.

  2018cites this paper
• Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts

  2018cites this paper
• Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity

  2018cites this paper
• PD-1 deficiency augments bone marrow failure in a minor-histocompatibility antigen mismatch lymphocyte infusion model.

  2018cites this paper
• Upfront Matched Unrelated Donor Transplantation in Aplastic Anemia.

  2018cites this paper
• Hematopoietic stem cell mobilization with plerixafor in sickle cell disease

  2018cites this paper
• (Auto-)immune signature in aplastic anemia

  2018cites this paper
• The Changes of the Levels of Tumor Necrosis Factor α, Interferon γ and Vascular Endothelial Growth Factor in the Sera of Children with Acquired Aplastic Anemia after Blood Transfusion

  2018cites this paper
• Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment

  2018cites this paper
• Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations

  2018cites this paper
• Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice

  2017cites this paper
• Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study

  2017influential citation
• Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review

  2017cites this paper
• Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia

  2017cites this paper
• A plasma microRNA signature as a biomarker for acquired aplastic anemia

  2017cites this paper
• Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation

  2017cites this paper
• T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways

  2017cites this paper
• Integrin αvβ3 enhances the suppressive effect of interferon‐γ on hematopoietic stem cells

  2017cites this paper
• Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia

  2016influential citation
• Modulation of Memory T Cells to Control Acquired Bone Marrow Failure

  2016cites this paper
• Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.

  2016cites this paper
• Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia

  2016influential citation
• Clonal hematopoiesis in acquired aplastic anemia.

  2016cites this paper
• High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

  2016cites this paper
• Bcl‐2 proteins in development, health, and disease of the hematopoietic system

  2016cites this paper
• Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.

  2016influential citation
• Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning

  2016cites this paper
• Anemia Aplástica Adquirida

  2016cites this paper
• Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia

  2016cites this paper
• Impaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance

  2016cites this paper
• Assessment of a One-Step Intracellular Staining in Th1, Th2 and Th17 Cells of Clinical Samples.

  2015cites this paper
• Interferon and tumor necrosis factor as humoral mechanisms coupling hematopoietic activity to inflammation and injury.

  2015cites this paper
• Reduced IL-33 plasma levels in aplastic anemia

  2015cites this paper
• Anti-inflammatory effects of interleukin-35 in acquired aplastic anemia.

  2015cites this paper
• Involvement of interleukin‐21 in the pathophysiology of aplastic anemia

  2015cites this paper
• Identification of novel microRNA signatures linked to acquired aplastic anemia

  2015cites this paper
• The complex pathophysiology of acquired aplastic anaemia

  2015cites this paper
• The association of cytokine genes polymorphisms and susceptibility to aplastic anemia in Egyptian patients

  2015cites this paper
• Anemia of Central Origin.

  2015cites this paper
• TRAF1/C5 rs10818488 polymorphism is not a genetic risk factor for acquired aplastic anemia in a Chinese population.

  2015cites this paper
• Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood

  2015cites this paper
• Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors

  2015cites this paper
• Basal level of Th17 immune response is not enhanced in aplastic amemia.

  2015cites this paper
• Bone marrow failure synd romes and refractory cytopenia of childhood

  2014influential citation
• Increased Bone Marrow (BM) Plasma Level of Soluble CD30 and Correlations with BM Plasma Level of Interferon (IFN)-γ, CD4/CD8 T-Cell Ratio and Disease Severity in Aplastic Anemia

  2014cites this paper
• Impact of interferon-γ on hematopoiesis.

  2014cites this paper
• Increased Expression of TIGIT on CD4+ T Cells Ameliorates Immune‐Mediated Bone Marrow Failure of Aplastic Anemia

  2014cites this paper
• Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia

  2014cites this paper
• Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice

  2014cites this paper
• IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.

  2014cites this paper
• The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.

  2014cites this paper
• Elucidating Cellular Signaling Pathways that Contribute to the Immunopathogenesis of Aplastic Anemia

  2014influential citation
• Aplastic Anemia in Mice Promotes Th 1 Cell Responses Mediating Posttranslational Expression of T-bet and Ezh 2 Regulates Transcriptional and

  2014cites this paper
• The pathophysiology of paroxysmal nocturnal haemoglobinuria

  2014cites this paper
• The optimal immunosuppressive therapy for aplastic anemia

  2013cites this paper